Osmotica Pharmaceuticals plc to Present at Jefferies London Virtual Healthcare Conference 2021
15 Novembro 2021 - 8:50AM
Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the
“Company”), a specialty pharmaceutical company, announced today
that Brian Markison, Chief Executive Officer, James “JD” Schaub,
Chief Operating Officer, and Andrew Einhorn, Chief Financial
Officer, will present at the Jefferies London Virtual Healthcare
Conference 2021 as follows:
Date: |
Thursday,
November 18, 2021 |
On Demand Time: |
8:00AM GMT (3:00AM ET) |
Webcast: |
https://wsw.com/webcast/jeff201/osmt/1869930 |
The presentation will be webcast on-demand and
available for 30 days thereafter using the link provided above and
via the Company’s website at www.osmotica.com under the “Investor
& News” section.
About Osmotica Pharmaceuticals
plcOsmotica Pharmaceuticals plc (Nasdaq: OSMT) is a
specialty pharmaceutical company focused on the development and
commercialization of products that target markets with underserved
patient populations. RVL Pharmaceuticals, Inc. is the Company’s
ophthalmic subsidiary supporting UPNEEQ®.
Osmotica has operations in the United States and
Hungary.
Investor and Media Relations for Osmotica
Pharmaceuticals plcLisa M. WilsonIn-Site Communications,
Inc.T: 212-452-2793E: lwilson@insitecony.com
Osmotica Pharmaceuticals (NASDAQ:OSMT)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Osmotica Pharmaceuticals (NASDAQ:OSMT)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024
Notícias em tempo-real sobre Osmotica Pharmaceuticals PLC da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de